Ferroelectric Hf 0.5 Zr 0.5 O 2 with Enhanced Intermediate Polarization: A Platform for Neuromorphic and Logic-in-Memory Computing
ACS Applied Materials & Interfaces · 04.06.2025 · 17 (22) · 32575-32585
DOI: 10.1021/acsami.4c21417 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, online erschienen am 20.05.2025. Verfasst von Heng Xiang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Electrical and Computer Engineering, National University of Singapore, 4 Engineering Drive 3, Singapore 117583, Singapore. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: National Research Foundation Singapore.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Electrical and Computer Engineering, National University of Singapore, 4 Engineering Drive 3, Singapore 117583, Singapore.
ORCID-Profile: Kah-Wee Ang
Förderung
- National Research Foundation Singapore
Zitieren
APA
Xiang, H., Li, L., Chien, Y. C., Zheng, H., Gao, J., & Ang, K. W. (2025). Ferroelectric Hf 0.5 Zr 0.5 O 2 with Enhanced Intermediate Polarization: A Platform for Neuromorphic and Logic-in-Memory Computing. ACS Applied Materials & Interfaces, 17(22), 32575-32585. https://doi.org/10.1021/acsami.4c21417
Vancouver
Xiang H, Li L, Chien YC, Zheng H, Gao J, Ang KW. Ferroelectric Hf 0.5 Zr 0.5 O 2 with Enhanced Intermediate Polarization: A Platform for Neuromorphic and Logic-in-Memory Computing. ACS Applied Materials & Interfaces. 2025;17(22):32575-32585. doi:10.1021/acsami.4c21417
BibTeX
@article{Xiang2025,
author = {Xiang, Heng and Li, Lingqi and Chien, Yu-Chieh and Zheng, Haofei and Gao, Jing and Ang, Kah-Wee},
title = {Ferroelectric Hf 0.5 Zr 0.5 O 2 with Enhanced Intermediate Polarization: A Platform for Neuromorphic and Logic-in-Memory Computing},
journal = {ACS Applied Materials & Interfaces},
year = {2025},
volume = {17},
number = {22},
pages = {32575--32585},
doi = {10.1021/acsami.4c21417}
}
EUVIMED